Responses
7th International Symposium on Advanced Ovarian Cancer
Changing the Paradigm in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: From Platinum Doublets to Nonplatinum Doublets and Adding Antiangiogenesis Compounds
Compose a Response to This Article
Other responses
No responses have been published for this article.